The Efficacy and Safety of Alemtuzumab in Auotoimmune Cytopenias

NCT00472433 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Stopped no eligible patient

Conditions

Autoimmune Cytopenias

Interventions

DRUG: Alemtuzumab

Sponsor

Phramongkutklao College of Medicine and Hospital

Collaborators

[object Object]